169 related articles for article (PubMed ID: 24875939)
1. Positron emission tomography and stage migration in head and neck cancer.
VanderWalde NA; Salloum RG; Liu TL; Hornbrook MC; O'Keeffe Rosetti MC; Ritzwoller DP; Fishman PA; Elston Lafata J; Khandani AH; Chera BS
JAMA Otolaryngol Head Neck Surg; 2014 Jul; 140(7):654-61. PubMed ID: 24875939
[TBL] [Abstract][Full Text] [Related]
2. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
4. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
Fogh SE; Kubicek GJ; Champ C; Intenzo C; Axelrod R; Keane WM; Machtay MM
Am J Clin Oncol; 2012 Aug; 35(4):311-5. PubMed ID: 22772424
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of
Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J
Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225
[TBL] [Abstract][Full Text] [Related]
6. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database.
Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
Clin Ther; 2018 Sep; 40(9):1522-1537. PubMed ID: 30150077
[TBL] [Abstract][Full Text] [Related]
8. Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.
Keane FK; Chen YH; Tishler RB; Schoenfeld JD; Haddad RI; Goguen LA; Catalano P; Neville BA; Margalit DN
Head Neck; 2016 Oct; 38(10):1530-8. PubMed ID: 27080700
[TBL] [Abstract][Full Text] [Related]
9. Insurance status, stage of presentation, and survival among female patients with head and neck cancer.
Panth N; Simpson MC; Sethi RKV; Varvares MA; Osazuwa-Peters N
Laryngoscope; 2020 Feb; 130(2):385-391. PubMed ID: 30900256
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
Moan JM; Amdal CD; Malinen E; Svestad JG; Bogsrud TV; Dale E
Radiother Oncol; 2019 Nov; 140():54-61. PubMed ID: 31177043
[TBL] [Abstract][Full Text] [Related]
11. 18F-Fluorodeoxyglucose-PET/CT in locally advanced head and neck cancer can influence the stage migration and nodal radiation treatment volumes.
Mazzola R; Alongi P; Ricchetti F; Fiorentino A; Fersino S; Giaj-Levra N; Salgarello M; Alongi F
Radiol Med; 2017 Dec; 122(12):952-959. PubMed ID: 28849308
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).
Agarwal M; Brahmanday G; Bajaj SK; Ravikrishnan KP; Wong CY
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):691-8. PubMed ID: 19915840
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcome for head and neck squamous cell carcinoma in a developing country: University Malaya Medical Centre, Malaysia from 2003-2010.
Wong YF; Yusof MM; Wan Ishak WZ; Alip A; Phua VC
Asian Pac J Cancer Prev; 2015; 16(7):2903-8. PubMed ID: 25854381
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
Van den Wyngaert T; Helsen N; Carp L; Hakim S; Martens MJ; Hutsebaut I; Debruyne PR; Maes ALM; van Dinther J; Van Laer CG; Hoekstra OS; De Bree R; Meersschout SAE; Lenssen O; Vermorken JB; Van den Weyngaert D; Stroobants S;
J Clin Oncol; 2017 Oct; 35(30):3458-3464. PubMed ID: 28854069
[TBL] [Abstract][Full Text] [Related]
15.
Pedraza S; Ruiz-Alonso A; Hernández-Martínez AC; Cabello E; Lora D; Pérez-Regadera JF
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):154-159. PubMed ID: 30655026
[TBL] [Abstract][Full Text] [Related]
16. Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.
Chen SW; Hsieh TC; Yen KY; Yang SN; Wang YC; Chien CR; Liang JA; Kao CH
Laryngoscope; 2014 Dec; 124(12):2732-8. PubMed ID: 25042474
[TBL] [Abstract][Full Text] [Related]
17. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of 2-[(18)F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria.
Min M; Lin P; Lee M; Ho Shon I; Lin M; Forstner D; Tieu MT; Chicco A; Bray V; Fowler A
Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):393-401. PubMed ID: 26782837
[TBL] [Abstract][Full Text] [Related]
19. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
Cacicedo J; Fernandez I; Del Hoyo O; Dolado A; Gómez-Suarez J; Hortelano E; Sancho A; Pijoan JI; Alvarez J; Espinosa JM; Gaafar A; Bilbao P
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
[TBL] [Abstract][Full Text] [Related]
20. The impact of institutional clinical trial recruitment versus hospital volume on survival outcomes of patients with head and neck cancer: An analysis of the PET-NECK trial outcomes, UKCRN portfolio, and Hospital Episode Statistics (HES) in England.
Lin DJ; McConkey CC; Nankivell P; Dunn J; Mehanna H
Oral Oncol; 2018 Oct; 85():40-43. PubMed ID: 30220318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
